Weight Loss NewsGet the Latest Weight Loss News |
| Bookmark This Page |
Sharepoint Mortgage Currency Teeth Whitening SAP Nouvelles de SAP SAP Nachrichten Obituary Software As A Service Bluetooth Product Recall Personal Injury DUI Business Software Medical Billing Software Laser Hair Removal Plastic Surgery Adipex Phentermine Petroleum Engineering Offshore Engineering CA |
Weight-Loss Expert JJ Smith Offers Free eBook, '5 Reasons You Can't Lose Weight!' |
FDA Advisory Panel Recommends Approval For Weight Loss Drug Lorcaserin 
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of lorcaserin (Lorqess, Arena). The result signals a remarkable turnaround for the drug, which the same panel had rejected in September 2010. The vote was 18 in favor of approval, 4 against, and 1 abstention. FDA advisers recommend approving weight loss drug
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks. Weight-loss drug Lorcaserin: Definite maybe in 2nd run at FDA's OK
The proposed weight-loss drug Lorcaserin, rebuffed in its bid for Food and Drug Administration approval last October, on Thursday won a recommendation of approval from the agency's advisory committee, a major step toward winning the FDA's go-ahead to enter the U.S. market. If the agency follows the advice of the panel of independent experts--which is common but not routine-- Lorcaserin would ... Lorcaserin weight loss drug wins thumbs up from FDA panel
SILVER SPRING, Md. -- For the second time in less than three months, an expert panel convened by the US Food and Drug Administration voted to recommend approval of a prescription weight loss drug that had previously been rejected because of safety concerns: Lorcaserin (Lorqess) was approved Thursday by an 18 to 4 vote with 1 abstention for its ability to help overweight people shed pounds with ... FDA Panel Gives Blessing to New Weight-Loss Drug Lorcaserin
If agency follows suit, lorcaserin could be first such medication approved in a decade FDA Panel Gives Blessing to New Weight-Loss Drug
THURSDAY, May 10 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects. FDA advisers recommend OK for weight loss drug
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks. Shares of the drug’s creator, Arena Pharmaceuticals Inc., nearly doubled, jumping from $3.66 to $7.15 in after-hours trading after trading was [...] FDA Panel Gives Nod to New Diet Drug
An FDA advisory committee has voted 18-4, with one abstention, in favor of approving Lorqess as the first new weight-loss drug in more than a decade. Some Question FDA Panel’s Approval Nod for New Weight Loss Drug
A U.S. Food & Drug Administration (FDA) panel’s backing of a new weight loss drug is being questioned. The drug, lorcaserin, received mixed approval from the agency’s outside advisers last Thursday. The panel voted 18 for approval and four against, … Continue reading → FDA panel backs Arena weight-loss pill lorcaserin
PHARMACEUTICALS FDA panel endorses weight-loss drug Arena Pharmaceuticals jumped the most ever Friday after the company's weight-loss pill gained the backing of an advisory panel, putting two obesity drugs in line for U.... Weight Loss News - Get the Latest Weight Loss News |
Copyright 2012
Get the Latest Weight Loss News
http://news.search.yahoo.com/news/rss?p=weight+loss&ei=UTF-8&fl=0&x=wrt
http://news.search.yahoo.com/news/rss?p=weight+loss+fda&ei=UTF-8&fl=0&x=wrt